Perbedaan Metro Healthcare Indonesia Tbk. dan Diagnos Laboratorium Utama Tbk.: Metro Healthcare Indonesia Tbk. diperdagangkan di Rp428 (kapitalisasi pasar 14,23 T, volume 24 jam 346,3 rb), sedangkan Diagnos Laboratorium Utama Tbk. diperdagangkan di Rp224 (kapitalisasi pasar 310,75 M, volume 24 jam 963,6 rb). Perbedaan utamanya: Metro Healthcare Indonesia Tbk. jauh lebih besar — sekitar 45,8× kapitalisasi pasar Diagnos Laboratorium Utama Tbk., dan Diagnos Laboratorium Utama Tbk. lebih aktif diperdagangkan (963,6 rb vs 346,3 rb). Mana yang lebih baik tergantung tujuan investasimu.
| CARE | DGNS | |
|---|---|---|
Kapitalisasi Pasar | 14,23 T | 310,75 M |
Volume | 346,3 rb | 963,6 rb |
Lot | 3,46 rb | 9,64 rb |
Perputaran | 147,93 jt | 217,67 jt |
Harga Rata-rata | 427,18 | 225,89 |
Nilai Transaksi | 147,93 jt | 217,67 jt |
Harga Ekuilibrium Indikatif | 428 | 226 |
Volume Ekuilibrium Indikatif | 10 | 1 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Metro Healthcare Indonesia Tbk (the “Company”) was established under the name PT Aruna Anjaya Perkasa, based on Notarial Deed No. 67 dated October 07, 2015 of Humberg Lie, S.H., S.E., M.Kn notary in Jakarta. The Company started its commercial operations in 2016 .
Selengkapnya di halaman CARE →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Selengkapnya di halaman DGNS →